This may be due to estrogen receptor (ER) expression, which has been shown to correlate with higher Th2 infiltration, decreased MHC class II expression on BC cells, suppression of interferon-γ (IFN-γ) signaling and decreased cytolytic function of CD8+T-cells [7,14,48]. The gene discussed is ESR1; the disease is breast cancer.